Neuberger Berman Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $246M | Buy |
551,522
+5,625
| +1% | +$2.62M | 0.19% | 114 |
|
|
2025
Q4 | $247M | Buy |
545,897
+18,406
| +3% | +$7.93M | 0.18% | 118 |
|
|
2025
Q3 | $207M | Buy |
527,491
+68,341
| +15% | +$28.6M | 0.15% | 149 |
|
|
2025
Q2 | $204M | Buy |
459,150
+16,522
| +4% | +$7.61M | 0.16% | 150 |
|
|
2025
Q1 | $215M | Buy |
442,628
+8,317
| +2% | +$3.88M | 0.18% | 138 |
|
|
2024
Q4 | $175M | Buy |
434,311
+5,173
| +1% | +$2.4M | 0.14% | 177 |
|
|
2024
Q3 | $200M | Buy |
429,138
+1,650
| +0.4% | +$793K | 0.16% | 168 |
|
|
2024
Q2 | $200M | Buy |
427,488
+13,438
| +3% | +$5.83M | 0.16% | 150 |
|
|
2024
Q1 | $173M | Buy |
414,050
+18,270
| +5% | +$7.72M | 0.14% | 185 |
|
|
2023
Q4 | $161M | Buy |
395,780
+57,855
| +17% | +$21.4M | 0.14% | 193 |
|
|
2023
Q3 | $118M | Buy |
337,925
+26,290
| +8% | +$9.19M | 0.11% | 241 |
|
|
2023
Q2 | $110M | Buy |
311,635
+8,617
| +3% | +$2.9M | 0.1% | 258 |
|
|
2023
Q1 | $95.5M | Buy |
303,018
+1,917
| +0.6% | +$575K | 0.09% | 283 |
|
|
2022
Q4 | $87M | Buy |
301,101
+35,292
| +13% | +$10.8M | 0.09% | 286 |
|
|
2022
Q3 | $77M | Sell |
265,809
-134,151
| -34% | -$38.6M | 0.08% | 314 |
|
|
2022
Q2 | $113M | Buy |
399,960
+157,191
| +65% | +$42.1M | 0.11% | 253 |
|
|
2022
Q1 | $63.4M | Sell |
242,769
-42
| -0% | -$9.97K | 0.05% | 410 |
|
|
2021
Q4 | $52.4M | Sell |
242,811
-43,385
| -15% | -$8.44M | 0.04% | 469 |
|
|
2021
Q3 | $51.6M | Sell |
286,196
-123,143
| -30% | -$24M | 0.05% | 457 |
|
|
2021
Q2 | $82.3M | Buy |
409,339
+20,324
| +5% | +$4.25M | 0.07% | 353 |
|
|
2021
Q1 | $83.3M | Sell |
389,015
-3,587
| -0.9% | -$788K | 0.08% | 334 |
|
|
2020
Q4 | $92.7M | Sell |
392,602
-45,197
| -10% | -$10.4M | 0.1% | 284 |
|
|
2020
Q3 | $119M | Buy |
437,799
+14,507
| +3% | +$4M | 0.14% | 208 |
|
|
2020
Q2 | $123M | Buy |
423,292
+38,240
| +10% | +$10.4M | 0.15% | 180 |
|
|
2020
Q1 | $91.6M | Buy |
385,052
+5,352
| +1% | +$1.23M | 0.14% | 200 |
|
|
2019
Q4 | $83.1M | Buy |
379,700
+6,350
| +2% | +$1.29M | 0.1% | 291 |
|
|
2019
Q3 | $63.3M | Buy |
373,350
+13,157
| +4% | +$2.33M | 0.08% | 344 |
|
|
2019
Q2 | $66.1M | Buy |
360,193
+11,863
| +3% | +$2.07M | 0.08% | 342 |
|
|
2019
Q1 | $64.1M | Buy |
348,330
+92,287
| +36% | +$17M | 0.08% | 344 |
|
|
2018
Q4 | $42.4M | Buy |
256,043
+6,951
| +3% | +$1.2M | 0.06% | 396 |
|
|
2018
Q3 | $48M | Buy |
249,092
+657
| +0.3% | +$117K | 0.05% | 418 |
|
|
2018
Q2 | $42.2M | Buy |
248,435
+3,696
| +2% | +$573K | 0.05% | 454 |
|
|
2018
Q1 | $39.9M | Buy |
244,739
+19,985
| +9% | +$3.26M | 0.05% | 464 |
|
|
2017
Q4 | $33.7M | Buy |
224,754
+1,277
| +0.6% | +$189K | 0.04% | 505 |
|
|
2017
Q3 | $34M | Sell |
223,477
-17,510
| -7% | -$2.64M | 0.04% | 485 |
|
|
2017
Q2 | $31.1M | Sell |
240,987
-5,344
| -2% | -$643K | 0.04% | 500 |
|
|
2017
Q1 | $26.9M | Buy |
246,331
+12,060
| +5% | +$1.06M | 0.03% | 525 |
|
|
2016
Q4 | $17.3M | Sell |
234,271
-343,963
| -59% | -$28M | 0.02% | 626 |
|
|
2016
Q3 | $50.4M | Sell |
578,234
-56,654
| -9% | -$5.35M | 0.07% | 374 |
|
|
2016
Q2 | $54.6M | Buy |
634,888
+95,740
| +18% | +$8.27M | 0.08% | 345 |
|
|
2016
Q1 | $42.9M | Sell |
539,148
-1,453
| -0.3% | -$131K | 0.06% | 400 |
|
|
2015
Q4 | $68M | Buy |
540,601
+28,747
| +6% | +$3.47M | 0.09% | 310 |
|
|
2015
Q3 | $53.3M | Buy |
511,854
+34,159
| +7% | +$4.39M | 0.07% | 350 |
|
|
2015
Q2 | $59M | Buy |
477,695
+50,367
| +12% | +$6.35M | 0.07% | 373 |
|
|
2015
Q1 | $50.4M | Buy |
427,328
+129,119
| +43% | +$15.5M | 0.05% | 423 |
|
|
2014
Q4 | $35.4M | Buy |
298,209
+249,358
| +510% | +$28.1M | 0.04% | 505 |
|
|
2014
Q3 | $5.49M | Sell |
48,851
-2,375
| -5% | -$226K | 0.01% | 944 |
|
|
2014
Q2 | $4.85M | Sell |
51,226
-1,725
| -3% | -$121K | ﹤0.01% | 980 |
|
|
2014
Q1 | $3.74M | Sell |
52,951
-3,822
| -7% | -$303K | ﹤0.01% | 975 |
|
|
2013
Q4 | $4.22M | Sell |
56,773
-1,060,728
| -95% | -$73.9M | ﹤0.01% | 924 |
|
|
2013
Q3 | $84.7M | Sell |
1,117,501
-984,883
| -47% | -$78.4M | 0.09% | 311 |
|
|
2013
Q2 | $168M | Buy |
+2,102,384
| New | +$155M | 0.2% | 154 |
|
Other funds holding VRTX
VCM
VPM
Neuberger Berman Group's VRTX Position: Q1 2026 in Review
Neuberger Berman Group increased its Vertex Pharmaceuticals (VRTX) stake by 1% in Q1 2026, buying an estimated $2.62M and bringing the position to 551,522 shares worth $246M. The position accounts for 0.19% of the portfolio, ranked #114.
Neuberger Berman Group first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $247M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Neuberger Berman Group held 551,522 shares of Vertex Pharmaceuticals worth $246M as of Q1 2026.
- Neuberger Berman Group bought 5,625 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.62M.
- Vertex Pharmaceuticals made up 0.19% of Neuberger Berman Group's portfolio in Q1 2026, its #114 holding.
- Neuberger Berman Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's Vertex Pharmaceuticals position peaked at $247M in Q4 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.